390 related articles for article (PubMed ID: 27638713)
41. Targeting mitochondria for neuroprotection in Parkinson's disease.
Schapira AH
Antioxid Redox Signal; 2012 May; 16(9):965-73. PubMed ID: 22229791
[TBL] [Abstract][Full Text] [Related]
42. The Parkinson's disease-related genes act in mitochondrial homeostasis.
Sai Y; Zou Z; Peng K; Dong Z
Neurosci Biobehav Rev; 2012 Oct; 36(9):2034-43. PubMed ID: 22771336
[TBL] [Abstract][Full Text] [Related]
43. [Future of gene therapy for Parkinson's disease].
Mochizuki H
Rinsho Shinkeigaku; 2004 Nov; 44(11):948-50. PubMed ID: 15651340
[TBL] [Abstract][Full Text] [Related]
44. Control of mitochondrial integrity in Parkinson's disease.
Vives-Bauza C; Tocilescu M; Devries RL; Alessi DM; Jackson-Lewis V; Przedborski S
Prog Brain Res; 2010; 183():99-113. PubMed ID: 20696317
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic strategies for Parkinson's disease based on data derived from genetic research.
Riess O; Berg D; Krüger R; Schulz JB
J Neurol; 2003 Feb; 250 Suppl 1():I3-10. PubMed ID: 12761628
[TBL] [Abstract][Full Text] [Related]
46. Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.
Villeneuve LM; Purnell PR; Boska MD; Fox HS
Mol Neurobiol; 2016 Jan; 53(1):171-186. PubMed ID: 25421206
[TBL] [Abstract][Full Text] [Related]
47. Parkin and PINK1 functions in oxidative stress and neurodegeneration.
Barodia SK; Creed RB; Goldberg MS
Brain Res Bull; 2017 Jul; 133():51-59. PubMed ID: 28017782
[TBL] [Abstract][Full Text] [Related]
48. Mitochondrial dysfunctions in Parkinson's disease.
Gautier CA; Corti O; Brice A
Rev Neurol (Paris); 2014 May; 170(5):339-43. PubMed ID: 24119854
[TBL] [Abstract][Full Text] [Related]
49. Mitochondria and Parkinson's Disease: Clinical, Molecular, and Translational Aspects.
Borsche M; Pereira SL; Klein C; Grünewald A
J Parkinsons Dis; 2021; 11(1):45-60. PubMed ID: 33074190
[TBL] [Abstract][Full Text] [Related]
50.
Li W; Fu Y; Halliday GM; Sue CM
Front Cell Dev Biol; 2021; 9():612476. PubMed ID: 34295884
[TBL] [Abstract][Full Text] [Related]
51. Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson's Disease.
Bajracharya R; Youngson NA; Ballard JWO
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991634
[TBL] [Abstract][Full Text] [Related]
52. Pathological and Therapeutic Advances in Parkinson's Disease: Mitochondria in the Interplay.
Naren P; Cholkar A; Kamble S; Khan SS; Srivastava S; Madan J; Mehra N; Tiwari V; Singh SB; Khatri DK
J Alzheimers Dis; 2023; 94(s1):S399-S428. PubMed ID: 36093711
[TBL] [Abstract][Full Text] [Related]
53. Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases.
Gureev AP; Popov VN
Neurochem Res; 2019 Oct; 44(10):2273-2279. PubMed ID: 30617864
[TBL] [Abstract][Full Text] [Related]
54. miR-7 Replacement Therapy in Parkinson's Disease.
Titze-de-Almeida R; Titze-de-Almeida SS
Curr Gene Ther; 2018; 18(3):143-153. PubMed ID: 29714132
[TBL] [Abstract][Full Text] [Related]
55. New insights into the complex role of mitochondria in Parkinson's disease.
Grünewald A; Kumar KR; Sue CM
Prog Neurobiol; 2019 Jun; 177():73-93. PubMed ID: 30219247
[TBL] [Abstract][Full Text] [Related]
56. Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.
Exner N; Lutz AK; Haass C; Winklhofer KF
EMBO J; 2012 Jun; 31(14):3038-62. PubMed ID: 22735187
[TBL] [Abstract][Full Text] [Related]
57. Facilitating Pro-survival Mitophagy for Alleviating Parkinson's Disease via Sequence-Targeted Lycopene Nanodots.
Xia X; Li H; Xu X; Zhao G; Du M
ACS Nano; 2023 Sep; 17(18):17979-17995. PubMed ID: 37714739
[TBL] [Abstract][Full Text] [Related]
58. Neuroprotective gene therapy for Parkinson's disease.
Tenenbaum L; Chtarto A; Lehtonen E; Blum D; Baekelandt V; Velu T; Brotchi J; Levivier M
Curr Gene Ther; 2002 Dec; 2(4):451-83. PubMed ID: 12477256
[TBL] [Abstract][Full Text] [Related]
59. Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.
Lopert P; Patel M
J Neural Transm (Vienna); 2016 Feb; 123(2):113-23. PubMed ID: 25749885
[TBL] [Abstract][Full Text] [Related]
60. Mitochondrial contribution to Parkinson's disease pathogenesis.
Schapira AH; Gegg M
Parkinsons Dis; 2011; 2011():159160. PubMed ID: 21687805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
